Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maxime Dougados

Showing results (521-530 of 600) with videos related to

Pageof 60
Sort By:
Annals of the Rheumatic Diseases|November 6, 2019
Efficacy and safety of ixekizumab through 52 weeks in two phase 3, randomised, controlled clinical trials in patients with active radiographic axial spondyloarthritis (COAST-V and COAST-W)Maxime Dougados, James Cheng-Chung Wei, Robert Landewé, et al.
Plos One|August 28, 2015
Increase in Dickkopf-1 Serum Level in Recent Spondyloarthritis. Data from the DESIR CohortGaetane Nocturne, Stephan Pavy, Saida Boudaoud, et al.
Annals of the Rheumatic Diseases|June 9, 2012
The ability of synovitis to predict structural damage in rheumatoid arthritis: a comparative study between clinical examination and ultrasoundMaxime Dougados, Valérie Devauchelle-Pensec, Jean François Ferlet, et al.
RMD Open|July 20, 2020
Considerations for improving quality of care of patients with rheumatoid arthritis and associated comorbiditiesTore K Kvien, Alejandro Balsa, Neil Betteridge, et al.
The Journal of Rheumatology|June 7, 2007
OMERACT/OARSI initiative to define states of severity and indication for joint replacement in hip and knee osteoarthritisLaure Gossec, Gillian Hawker, Aileen M Davis, et al.
Clinical and Experimental Rheumatology|April 7, 2016
Clinical experience with the European Ankylosing Spondylitis Infliximab Cohort (EASIC): long-term extension over 7 years with focus on clinical efficacy and safetyFrank Heldmann, Xenofon Baraliakos, Uta Kiltz, et al.
Joint Bone Spine|July 21, 2015
Clinical presentation of patients suffering from recent onset chronic inflammatory back pain suggestive of spondyloarthritis: The DESIR cohortMaxime Dougados, Adrien Etcheto, Anna Molto, et al.
Annals of the Rheumatic Diseases|May 21, 2015
Evidence for treating rheumatoid arthritis to target: results of a systematic literature search updateMichaela A Stoffer, Monika M Schoels, Josef S Smolen, et al.
Annals of the Rheumatic Diseases|September 9, 2018
Characteristics of difficult-to-treat rheumatoid arthritis: results of an international surveyNadia M T Roodenrijs, Maria J H de Hair, Marlies C van der Goes, et al.
Rheumatology (Oxford, England)|October 16, 2020
Evaluation of the impact of a nurse-led program of patient self-assessment and self-management in axial spondyloarthritis: results of a prospective, multicentre, randomized, controlled trial (COMEDSPA)Anna Molto, Laure Gossec, Serge Poiraudeau, et al.
Pageof 60

Showing results (521-530 of 600) with videos related to

Sort By:
Pageof 60
Annals of the Rheumatic Diseases|November 6, 2019
Efficacy and safety of ixekizumab through 52 weeks in two phase 3, randomised, controlled clinical trials in patients with active radiographic axial spondyloarthritis (COAST-V and COAST-W)Maxime Dougados, James Cheng-Chung Wei, Robert Landewé, et al.
Plos One|August 28, 2015
Increase in Dickkopf-1 Serum Level in Recent Spondyloarthritis. Data from the DESIR CohortGaetane Nocturne, Stephan Pavy, Saida Boudaoud, et al.
Annals of the Rheumatic Diseases|June 9, 2012
The ability of synovitis to predict structural damage in rheumatoid arthritis: a comparative study between clinical examination and ultrasoundMaxime Dougados, Valérie Devauchelle-Pensec, Jean François Ferlet, et al.
RMD Open|July 20, 2020
Considerations for improving quality of care of patients with rheumatoid arthritis and associated comorbiditiesTore K Kvien, Alejandro Balsa, Neil Betteridge, et al.
The Journal of Rheumatology|June 7, 2007
OMERACT/OARSI initiative to define states of severity and indication for joint replacement in hip and knee osteoarthritisLaure Gossec, Gillian Hawker, Aileen M Davis, et al.
Clinical and Experimental Rheumatology|April 7, 2016
Clinical experience with the European Ankylosing Spondylitis Infliximab Cohort (EASIC): long-term extension over 7 years with focus on clinical efficacy and safetyFrank Heldmann, Xenofon Baraliakos, Uta Kiltz, et al.
Joint Bone Spine|July 21, 2015
Clinical presentation of patients suffering from recent onset chronic inflammatory back pain suggestive of spondyloarthritis: The DESIR cohortMaxime Dougados, Adrien Etcheto, Anna Molto, et al.
Annals of the Rheumatic Diseases|May 21, 2015
Evidence for treating rheumatoid arthritis to target: results of a systematic literature search updateMichaela A Stoffer, Monika M Schoels, Josef S Smolen, et al.
Annals of the Rheumatic Diseases|September 9, 2018
Characteristics of difficult-to-treat rheumatoid arthritis: results of an international surveyNadia M T Roodenrijs, Maria J H de Hair, Marlies C van der Goes, et al.
Rheumatology (Oxford, England)|October 16, 2020
Evaluation of the impact of a nurse-led program of patient self-assessment and self-management in axial spondyloarthritis: results of a prospective, multicentre, randomized, controlled trial (COMEDSPA)Anna Molto, Laure Gossec, Serge Poiraudeau, et al.
Pageof 60